Beyer, 2024 - Google Patents
From Radiochemistry of the Lanthanides to 225Ac and the Interference with Richard BaumBeyer, 2024
View HTML- Document ID
- 160382565170364998
- Author
- Beyer G
- Publication year
- Publication venue
- Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum
External Links
Snippet
Abstract In 1990, Heinz Schelbert, one of the pioneers of PET, has been asked during an invited lecture at the ZfK Rossendorf, why it happens that few newly created PET centers have significant success and others do not have at all. His answer was simple and clear …
- 229910052747 lanthanoid 0 title description 75
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/10—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/04—Radioactive sources other than neutron sources
- G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/06—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by neutron irradiation
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/001—Recovery of specific isotopes from irradiated targets
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/0005—Isotope delivery systems
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Naskar et al. | Theranostic terbium radioisotopes: challenges in production for clinical application | |
| McCarthy et al. | Efficient production of high specific activity 64Cu using a biomedical cyclotron | |
| Misiak et al. | 47Sc production development by cyclotron irradiation of 48Ca | |
| Beyer et al. | Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab | |
| Loveless et al. | Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47Sc | |
| CA2594829C (en) | Method for production of radioisotope preparations and their use in life science, research, medical application and industry | |
| Qaim et al. | Development of novel radionuclides for medical applications | |
| Beyer et al. | Production routes of the alpha emitting 149Tb for medical application | |
| Fiaccabrino et al. | Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb | |
| Moiseeva et al. | Cross section measurements of 151Eu (3He, 5n) reaction: new opportunities for medical alpha emitter 149Tb production | |
| Andrighetto et al. | The ISOLPHARM project: ISOL-based production of radionuclides for medical applications | |
| Sadler et al. | Cutting edge rare earth radiometals: prospects for cancer theranostics | |
| Qaim | Use of cyclotrons in medicine | |
| Srivastava et al. | Therapeutic radionuclides: production, physical characteristics, and applications | |
| Stevenson et al. | Methods of producing high specific activity Sn-117m with commercial cyclotrons | |
| Chernysheva et al. | Accelerator production of scandium radioisotopes: Sc-43, Sc-44, and Sc-47 | |
| Kazakov et al. | Separation of radioisotopes of terbium from a europium target irradiated by 27 MeV α-particles | |
| Kazakov | Terbium isotopes in nuclear medicine: production, recovery, and application | |
| Abel et al. | Production, collection, and purification of 47Ca for the generation of 47Sc through isotope harvesting at the national superconducting cyclotron laboratory | |
| Aliev et al. | Photonuclear production of medically relevant radionuclide 47Sc | |
| Bernerd et al. | Production of innovative radionuclides for medical applications at the CERN-MEDICIS facility | |
| Pupillo et al. | The LARAMED project at INFN-LNL: review of the research activities on medical radionuclides production with the SPES cyclotron | |
| Nagai | Production scheme for diagnostic-therapeutic radioisotopes by accelerator neutrons | |
| McNeil et al. | From cyclotrons to chromatography and beyond: a guide to the production and purification of theranostic radiometals | |
| Vallabhajosula | Production of radionuclides |